
The company says the certification guarantees that the plant has an adequate system for controlling-and improving, in the future-its environmental impact.

The company says the certification guarantees that the plant has an adequate system for controlling-and improving, in the future-its environmental impact.

In the midst of the well-publicized legal fight between POM Wonderful (Los Angeles) and the FTC, there appears to be some good news-for the larger dietary supplements industry, at least.

Senator Durbin wants FDA to crack down on energy drinks. But does current law allow FDA to do so?

OHSAS stands for Occupational Health and Safety Assessment Series, which certifies the management of health and safety in the workplace.

An FTC administrative law judge has ruled that POM Wonderful violated federal law.

CRN estimates each AER may take between 2 to 10 hours per report.

The agency claimed supporting science, provided by Merck, was "weak."

With USP’s D-IVP certification, Parry Organic Spirulina can now bear the USP Verified Mark on product labels and certificates of analysis.

The company produces the AlaskOmega line of omega-3 nutritional supplement concentrates.

ISO 17025 is the international standard for testing and calibration laboratories.

Medical Brands (Amsterdam) and Decas Botanical Synergies (Carver, MA) have earned EU medical device status for their Cranberry-Active Bladder Capsules, intended to treat or prevent urinary tract infections (UTIs).

The USDA's new standards and grades apply to American and Asian ginseng.

Oy, Canada! Is a Natural Health Products Act rising?

Companies need a workable time frame in which to comply with the European Commission's Article 13.1 health claims regulation.

Nondigestible polysaccharides are on the verge of something big.

A USDA-proposed rule would clarify which synthetic ingredients can be added to organic food and infant formula.

What to consider if the clinical trial substantiating your U.S. advertising claim is conducted in a foreign country.

A new generation of natural colors is having to jump stability hurdles relating to temperature, acidity, and co-formulated ingredients. How are suppliers adapting?

Will the wrong trial design make your dietary supplement or functional food an unregistered drug?

The Food and Drug Administration (FDA) must reconsider imposing the pre-market approval paradigm of food additives to dietary supplements as proposed in its New Dietary Ingredient (NDI) Draft Guidance, according to a commentary by the Council for Responsible Nutrition (CRN).

Jungbunzlauer has recently started producing pure L(+)-lactic acid, sodium lactate, and potassium lactate by traditional fermentation of natural, non-GM carbohydrates.

The company says that AstraGin has been demonstrated in vitro, in vivo, and in humans to significantly promote and improve absorption of amino acids, glucose, and vitamins.

The company has received the AIB International (American Institute of Baking) highest rating of "superior" for the 8th straight year.

The company has petitioned FDA for a qualified health claim for whole grains and certain food products containing whole grains.

“More and more, consumers are using the Natural Seal to find natural products at their favorite stores," says NPA president Jeff Wright.

The Argentine National Administration of Drugs, Foods and Medical Devices’ (ANMAT) newly introduced guidelines on the assessment of health claims in food advertising is an example of a growing trend towards the regulation of health claims in Latin America, an EAS adviser has said.

NSF says that more than 60% of dietary supplement ingredients sold in the United States are imported from China.

The list no longer includes Canadian operations, which thanks to a recent U.S.-Canada partnership means those companies no longer need to maintain certification according to USDA organic standards in order to sell organic products in the United States.

Recognizing the distinction between the two types of claims could have helped avoid the high number of “unnecessary” claims rejections.

Such claims include ones that EFSA at first judged as having insufficient supportive evidence and had requested submitters to provide more information.